FDA Investigator: Ruo H. Xu

- Ruo H. Xu first started conducting FDA inspections in 2017, with the last inspection in 2024. Over that time, Ruo H. Xu has conducted 14 inspections at 13 companies across 14 sites.

Get Ruo Xu's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.

Documents

Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 NerPharMa S.r.l., Nerviano | 2024

Out-of-stock
Ruo H. Xu
Human Drugs Form 483

FDA 483 Baxter Pharmaceutical Solutions, LLC, Bloomington | 2024

Out-of-stock
Ruo H. Xu
Human Drugs Form 483

FDA 483 Sunshine Lake Pharma Co., Ltd, Dongguan | 2019

Out-of-stock
Ruo H. Xu
Human Drug Form 483

FDA 483 Intelgenx Corp., Saint-Laurent | 2019

Out-of-stock
Ruo H. Xu
Human Drug Form 483

FDA 483 Amneal Pharmaceuticals, Inc., Brookhaven | 2019

Out-of-stock
Ruo H. Xu
Human Drug Form 483

FDA 483 Bausch & Lomb, Inc. a Division of Valeant Pharmaceuticals, Tampa | 2017

Out-of-stock
Ruo H. Xu
Human Drug Form 483

FDA 483 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd, Hangzhou | 2017

Out-of-stock
Ruo H. Xu
Human Drug Form 483

FDA 483 Holopack Verpackungstechnik GmbH, Sulzbach-Laufen | 2017

Out-of-stock
Ruo H. Xu
Human Drug Form 483